Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Feb 9;17(2):e0263374. doi: 10.1371/journal.pone.0263374

The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among black Tanzanian women: A case control study

Larry Onyango Akoko 1,*, Amonius K Rutashobya 1,¤, Evelyne W Lutainulwa 2, Ally H Mwanga 1, Sokoine L Kivuyo 3
Editor: David Teye Doku4
PMCID: PMC8827470  PMID: 35139096

Abstract

Purpose

This study aimed to determine the effect of reproductive, hormonal, lifestyle and nutritional factors on breast cancer development among Tanzanian black women.

Methodology

We undertook a case-control study age-matched to ±5years in 2018 at Muhimbili National Hospital. The study recruited 105 BC patients and 190 controls giving it 80% power to detect an odds ratio of ≥2 at the alpha error of <5% for exposure with a prevalence of 30% in the control group with 95% confidence. Controls were recruited from in patients being treated for non-cancer related conditions. Information regarding hormonal, reproductive, nutritional and lifestyle risk for breast cancer and demography was collected by interviews using a predefined data set. Conditional multinomial logistic regression used to determine the adjusted odds ratio for variables that had significant p-value in the binomial logistic regression model with 5% allowed error at 95% confidence interval.

Results

The study recruited 105 cases and 190 controls. Only old age at menopause had a significant risk, a 2.6 fold increase. Adolescent obesity, family history of breast cancer, cigarette smoking and alcohol intake had increased odds for breast cancer but failed to reach significant levels. The rural residency had 61% reduced odds for developing breast cancer though it failed to reach significant levels.

Conclusion

Older age at menopause is a significant risk factor for the development of breast cancer among Tanzanian women. This study has shed light on the potential role of modifiable risk factors for breast cancer which need to be studied further for appropriate preventive strategies in similar settings.

Background

Breast cancer (BC) is now the leading cause of cancer globally, surpassing lung cancer by contributing to 2.3million new cases and 684,679 cancer related deaths [1]. The burden of BC has geographical variability with an elevated incidence in high-income countries [2]. In spite of a somewhat low burden, it is second only to cervical cancer in many sub-Saharan African countries [3]. In Tanzania, it is estimated that BC contributes to 3,037 (7.2%) incident cancer cases and 1,303 (4.6%) cancer-related deaths [4]. This makes the control of BC an important public health priority in many countries including in Tanzania.

The global burden of cancer had recently shifted to low and middle income countries that now account for 57% of new diagnoses and 65% of all cancer related deaths [5]. About half of new BC diagnosis and more than half of its related deaths are now in LMICs [6, 7]. Transitioning countries in Africa, Asia, and America are experiencing rising incident rates [8]. The exact reason for this increase in burden is not fully understood due to lack of understanding on the local risk factors. Failure to understand the local risk factors, coupled with late presentation due to lack of screening services among other reasons, might be responsible for the rising case fatalities rate in most of sub-Saharan Africa.

Most of the known risk factors have only been fully studied in western countries but not in low income countries. Studying BC risk factors is important as non-hereditary risk factors are responsible for the vast majority of cases [9]. There is limited knowledge on how geographic variability is related to the etiologic factors that have been studied. Understanding how the hormonal (exogenous and endogenous), anthropometric and lifestyle risk factors have shaped the epidemiology of BC is vital. This will allow adoption of local strategies to address the burden of BC in these settings. This study, therefore, was designed to understand the role of the known etiologic risk factors for BC among indigenous Tanzanian women with BC. This paper presents the association between reproductive, hormonal, nutritional and lifestyle risk factors for BC among Tanzanian black women.

Materials and methods

Study design and setting

This was a case-control study utilizing a locally designed and pretested questionnaire designed to evaluate the potential effect of the known reproductive, hormonal, lifestyle and nutritional risk factors for the development of breast cancer (BC) among indigenous Tanzanian women. The study was conducted at Muhimbili National Hospital (MNH) in 2018 for 4 months between August and December. MNH is a publicly owned teaching and national tertiary referral hospital affiliated with Muhimbili University of Health and Allied Sciences (MUHAS). The hospital is a multi-disciplinary entity receiving all kinds of diagnoses, benign and malignant, surgical, and medical. Patients with suspected and confirmed diagnosis of BC are derived from the whole country, as it is the only hospital where comprehensive cancer services can be offered in the country along with its sister institution (Ocean Road Cancer Institute) that offers medical and radiation therapy. The hospital also enjoys a mixture of public and private patients. This makes MNH an ideal recruitment center for both the cases and controls.

Inclusion criteria

Cases

The study identified all consecutive cases suspected or diagnosed with BC in the surgical wards of the hospital. Patients with a breast lump underwent Fine Needle Aspiration Cytology (FNAC) or a core needle biopsy where FNAC was none conclusive to confirm the diagnosis. For cases that came with a confirmed diagnosis from another facility, a slide block review was carried out at our pathology laboratory. The presence of pathologist signed report with assigned histology or cytology number from MNH central pathology laboratory was considered diagnostic hence assigned as cases. Additionally, cases were indigenous Tanzanian women with no racial mix and with no previous residence in any high income country. Cases were consecutively recruited to the desired sample size from the inpatient. At the end of the recruitment, cases were found to be between 25 and 85 years of age.

Controls

Controls were considered to be women who were ≥20 years of age, unrelated to the cases, with no prior history of breast disease or any malignancy and no history of residency in a high income country at any one point. They were selected among patients admitted in general medical wards for non-malignancy related conditions. Once a case was identified, two suitable controls were identified age-matched to ±5 years within 48hours of identification of cases (age range of the controls was between 21 and 8 4years). A physical breast examination was carried out to rule out any breast lump: there was no mandatory requirement for mammographic evaluation to rule out subclinical breast lumps. Both cases and controls were indigenous African women who were Tanzanian nationals with no history of having stayed outside the country at any point in time.

Study variables

A survey instrument was developed to capture the participant’s sociodemographic details that included: a date of birth in years; highest level of education awarded; residency as rural is settling in the village or urban for both small and large towns; occupation as source of income for managing daily living; and marital status as categorised into two groups as the unmarried comprising of single, widowed and divorcees, and the married for those in any stable relationship as marriage or cohabiting. Risk factors collected were related to the age of onset of menarche and menopause: menarche was taken as the occurrence of a first menstrual flow, while menopause was considered when a woman reported 12 consecutive months with no menses either spontaneous or post-surgery. Twelve (12) years and 45 years was set to determine early vs delayed onset for menarche and menopause respectively age at first childbirth included live births or pregnancy loss beyond eight months with categorization as parous or nulliparous, delivery beyond 35 years was considered as late. Additional factors collected included history of breast feeding (BF), ever use of any modern contraceptives to control child birth, fertility drug use to stimulate ovulation use, any alcoholic substance use, active smoking. Any breast cancer reported by a first degree relative was also collected. A self-reported sense of obesity during adolescent life was the only nutritional component assessed.

Study power

The study initially aimed to recruit 87 cases and 174 controls; however, due to the ease of accrual of cases, we managed to recruit 105 BC patients and 190 controls. This allowed the study to have 80% power to detect an odds ratio of ≥2 at the alpha error of <5% for exposure with a prevalence of 30% of the risk factor in the control group with 95% confidence.

Data collection

A predesigned English questionnaire was translated to Swahili and back translated to English. This was field tested for validity and reliability on 10 patients and 10 controls. Two research assistants were trained to administer the questionnaire to the study subjects. Once patient with a breast mass was identified, preliminary screening including obtaining consent was done. Upon confirmation of histology with available signed report, those meeting the study inclusion criteria then underwent a complete data abstraction through a provider administered interview to complete the questionnaire. Concurrently, for every case recruited, an age matched control was sought from the medical ward within 48 hours of the case identification. The same questionnaire used by the cases was administered for the controls.

Data analysis

After checking for completeness, the collected data were de-identified to keep study subjects anonymity and entered into Statistical Package for Social Scientists (SPSS) version 24.0 for further analysis. Cochran-Mantel-Hanszel (CMH) testing, stratified by the case-control pair was used to identify the risk factors for BC in a binomial logistic analysis, which provided estimates of the odds ratios (OR) and 95% confidence intervals (CI) of the risk factors. Furthermore, multinomial logistic regression was performed for variables that showed significant levels in CHM logistic regression modeling: a backward stepwise selection of variables whose p-value was ≤0.07. The adjusted ORs and corresponding 95% CI’s from this final model provided the comprehensive and less biased estimates of the risk factors associated with BC after adjusting for possible confounding variables and covariates.

Ethical consideration

The study protocol was reviewed and approved by the Muhimbili University of Health and Allied Sciences Institutional Review Board. Separate permission was also obtained from MNH education, research, and consultancy bureau. Written informed consent was obtained in Swahili from all participants before enrolment. There was no monetary compensation to the participants. Private consultation rooms were used to conduct interviews to ensure privacy and confidentiality. To protect patient health information, no names were recorded, and each participant was assigned a unique study identification number. Furthermore, this study] adhered to the Helsinki declaration on studies involving human subjects.

Results

During the study period, 105 cases and 190 age matched controls were recruited into the study, giving a case to control ratio 0f 1:1.8. Table 1 represents the demographic characteristics of the study subjects. Controls and cases were similar in all aspects except for: age where by cases were about five year’s younger (p = 0.006); and there were 13.9% control group coming from urban residence (p = 0.19).

Table 1. Comparing sociodemographic characteristics of breast cancer patients and their age matched controls at Muhimbili National Hospital, Dar es Salaam.

Variable Case Control P-value
Patients mean Age 49.55±13.8 44.95±13.5 0.006
(25–85) (21–84)
Education level
 Primary and less 82 (78.1%) 135 (71.1%) 0.189
 Secondary and above 23 (21.9%) 55 (28.9%)
Residence
 Urban 55 (52.4%) 126 (66.3%) 0.019
 Rural 50 (47.6%) 64 (33.7%)
Occupation
 Formally Employed 14 (13.3%) 31 (16.3%) 0.495
 Unemployed 91 (86.7%) 159 (86.7%)
Marital status
 Unmarried 46 (43.8%) 65 (34.2%) 0.103
 Married 59 (56.2%) 125 (65.8%)

Binomial logistic regression

Since age and residency were not uniformly distributed between cases and controls, they were added to the binomial regression model along with other known risk factors to study any association with BC risks in Table 2. Family history of breast cancer (p, 0.006), Cigarette smoking (p, 0.004), adolescent obesity (p, 0.0007), age at menopause below 45 years (p, 0.07), and older mean age (p, 0.006) had shown significant. The rural residency was found to be protective for BC development, with a 56% reduced risk among female with rural residency (p, 0.019). The following factors had increased risk but failed to rich significant levels: alcohol intake had 43% increased risk, and null parity had 2.5 more risks.

Table 2. Showing binary analysis results comparing cases and controls for risk factors for breast cancer development among African women in Tanzania.

RISK FACTOR CASE CONTROL OR P-value 95% CI
Family history of breast cancer 16 (15.2%) 10 (5.3%) 3.2 0.006 1.40–7.40
Adolescent obesity 46 (43.8%) 53 (27.9%) 2.0 0.0007 1.20–3.32
Cigarette Smoking 12 (11.4%) 5 (2.6%) 4.7 0.004 1.63–13.96
Alcohol intake 43 (41.0%) 62 (32.6%) 1.43 0.15 0.87–2.35
First delivery below 35 yrs. 96 (91.4%) 182 (95.8%) 0.79 0.79 0.12–4.78
Null parity 8 (7.6%) 6 (3.2%) 2.5 0.94 0.85–7.5
Contraceptive use a 56 (53.3%) 99 (52.1%) 1.05 0.84 0.65–1.69
Breast feeding 96 (98%) 184 (99.5%) 0.26 0.28 0.02–2.90
Infertility drug use b 14 (13.3%) 26 (13.9%) 0.97 0.93 0.48–1.95
Age at menarche (years) 1.13 0.83 0.36–3.58
 < 12 5 (4.7%) 8 (4.2%)
 ≥ 12 100 (95.2%) 182 (95.8%)
Age at menopause c (years)
 < 45 16 (28.1%) 10 (14.7%) 2.26 0.07 0.93–5.49
 ≥ 45 41 (71.9%) 58 (85.3%)
Mean age in years (range) 49.55±13.8 (25–85) 44.95±13.5 (21–84) 0.97 0.006 0.96–0.99
Residence
 Urban 55 (52.4%) 126 (66.3%) 0.56 0.019 0.343–0.91
 Rural 50 (47.6%) 64 (33.7%)

a Any reported use of a modern contraceptive method.

b Any reported modern medicine taken to boost ovulation or sustain a pregnancy.

c Only 57 cases and 68 controls had attained menopause at the time of the study.

Multinomial conditional logistic regression

The following factors which had a p-value of ≤0.07 from the CHM model were brought into the multinomial logistic regression model in Table 3 below: participants mean age, family history of BC, history of smoking, age at menopause, history of obesity, and place of residence. AOR with a 95% confidence interval was then calculated in the multinomial model. Attaining menopause above 45 years of age had a 2.6-fold increased risk of developing BC and this was significant (p = 0.045, 95%CI 1.02–6.94). The presence of adolescent obesity had a 2-fold increased risk but failed to reach significant levels (p = 0.064, 95%CI 0.96–4.66). Similarly, smoking and family history of BC had 3-fold and 2-fold increased risk respectively but failed to reach significant levels (p = 0.13, 95%CI 0.74–11.55, and p = 0.153, 95%CI 0.75–7.11 respectively). The Urban residency seemed to have an insignificant, (p = 0.22, 95%CI 0.28–1.34), protective effect with a 0.61 reduced odds of developing breast cancer compared with rural residency.

Table 3. Multinomial logistic regression analysis showing the strength of the association between selected variables and the risk of breast cancer among African Tanzanians.

RISK FACTOR AOR P-Value CI (95%)
Mean age 1 0.94 0.96–1.04
Family history
 Present 2.29 0.153 0.75–7.11
 Absent 1
Cigarette Smoking
 Yes 2.92 0.13 0.74–11.55
 No 1
Residence
 Urban 0.61 0.22 0.28–1.34
 Rural 1
Adolescent obesity
 Present 2.09 0.065 0.95–4.6
 Absent 1
Age at menopause
 < 45 2.63 0.047 1.01–6.83
 ≥ 45 1

Discussion

This study evaluates the role of age, hormonal, reproductive, and lifestyle risk factors for BC among indigenous Tanzanian women. While some of the risk factors we present are the same as those in HICs, others did not prove to be relevant in our setting and hence remain controversial calling for more expanded epidemiological studies.

Reproductive factors

Early age at menarche, null parity, older age at first childbirth, not breastfeeding, and older age at menopause are long known to be associated with an increase in BC risk in high income and transitioning countries [10]. While onset of menarche and menopause “cannot” be controlled, the majority of Tanzanian women: had first child birth when they were younger than 35 years of age and had more than one child birth. Likewise, most of these women were breastfeeding unlike in the west. These observations can explain the seemingly low prevalence of BC in this community compared to the west. Multi parity found in this study has been associated with a higher prevalence of breastfeeding (BF). Studies have shown that BF confers additional benefits to the woman such as prevention of endometrial and ovarian cancer, diabetes, and hypertension as well [1113]. BF for 12 months consecutively has been shown to reduce the lifetime risk for the development of BC by 4.3%, whereas each additional parity conferred a 7% reduced risk [14]. But why such a high parity and prevalent BF did not confer prevention in Tanzanian women needs to be studied further. Is there an underlying factor that is inherent to being an indigenous African?

Although multiparity is protective for BC, new evidence suggests that it is only protective towards the hormone receptor-positive BC subtypes but increases the risk for the hormone receptor negative and triple-negative BC subtypes [15, 16]. Parous women are 2.8 times more likely than nulliparous women to develop triple-negative BC, but prolonged BF can reduce this risk [17]. The protective role of BF has not been documented in Herceptin-2 positive tumors but only limited to triple-negative and luminal tumors [18]. Given that black women are more prone to develop triple negative BC subtypes [19], Tanzanian women stand to benefit from continued practicing BF. The practice of BF has the potential to significantly reduce the Triple negative BC subtypes among black Tanzanian women [20]. Opportunities to promote BF should be protected to maintain the higher BF rates reported in this study.

We did not collect data on the molecular subtypes of BC to study this interesting association since they are not routinely collected during work up. Previous studies suggest that more than half of women with BC in Tanzania are hormone receptor negative [21]. Likewise, up to one third of patients are reported to have a triple negative BC [22]. These two findings might explain the failure of BF and other hormonal risk factors to protect local Tanzanian women. While we encourage Tanzanian women to continue BF for its overall health benefit, these observed epidemiological factors need to be investigated alongside histological subtypes of breast cancer in the indigenous African setting.

Hormonal

The hormonal risk for the development of BC is a well-proven fact, predominantly through the Estrogen and Progesterone receptors [23]. Hormonal risk factors are associated with hormone receptor-positive BC and not the hormone receptor-negative subtypes. Oral contraceptives have not demonstrated any additional risk for BC development over the past 20 years or so [24]. However, there is a possibility of dose-response dependence. Our study only examined the question of ever use, while the answer lies in the duration of usage. Future case control studies should include data on duration of usage for hormonal contraceptive and analyze data inclusive of tumor biology to hormone receptor status.

Lifestyle

Obesity has controversial relationship with the development of breast cancer with a reduction in risk when it occurs at teenage and a modest increase when it develops after teenage [25]. In spite of this, weight loss from the most of adult life is known to reduce the BC risk [26]. This study could not make conclusive statements on obesity since it relied on individual recall of feeling obese during the adolescent period. Health records on individuals are lacking in Tanzania even when hospital visits have taken place. Moreover, BMI is not routinely assessed in many health visit encounters in Tanzania. Establishing BMI among patients during presentation in our setting has the potential of not yielding true results given the predominant late presentation and the possible accompanied tumor related weight loss. Nevertheless, future studies should include data on actual BMI by taking actual measurements or calculating from the last known weight. Likewise, dietary habits of these women with breast cancer need to be investigated. While establishing obesity during the index illness was made difficult by the BC associated weight loss, promoting weight loss should be given priority among women.

Even though women consuming any alcoholic drink were twice at risk for the development of BC compared to those who did not, caution is needed in interpreting the failure to reach the desired significance level. This could be due to the small sample size and this study was not powered to detect alcohol effect. It has been shown that alcohol increases mammographic density, a known risk factor for developing BC [27]. About 1–2 drinks per day have been linked with a 15–30% increased risk for BC [28]. With 41% of cases and 32% of controls reporting ever drinking, alcohol effect can be studied longitudinally to establish its exact role on BC causation in our setting. Since there are different types of drinks, local and commercial brew, these need to be taken into consideration when investigating the potential role of alcohol.

Mammary tissue is capable to uptake various tobacco carcinogens, including polycyclic aromatic hydrocarbons, aromatic amines, and N-nitrosamines which have demonstrated an in vitro capacity to induce malignancy in breast cells [29]. Thus smoking has been positively linked to the development of BC [30], especially the hormone receptor-negative subtype but not on the triple-negative [31]. This is almost similar to what we report, though it failed to reach confidence levels set for the study. Since smoking is modifiable, more studies to establish a clear link among Tanzanian women who develop BC are needed. It is important that characterization of smoking among Tanzanian women be carried out to fully understand how it relates to BC development.

There were more BC patients in our study that had urban residences than those from rural residence. This finding is similar to that from China that concluded that BC is actually higher among urban women probably due to a higher socioeconomic status compared with rural women [32]. Westernization and changing reproductive patterns accompanying urban life in China has been linked to an increase in BC incidence [33]. There are similar reports of rural-urban disparities in BC risk from India, with reproductive and central adiposity to blame [34]. The rural-urban incident disparity of BC in Tanzania needs to be confirmed and established by a larger, multicenter study.

The study being set only for patients reaching a tertiary hospital for treatment has the potential of misrepresenting the true rural-urban disparity of BC. It is known that risk factors distribution might not be the same between rural and urban dwellers, especially on modifiable ones [35]. With Tanzania eying middle income status, more women are going to migrate to urban locations and this pose a threat to increase in the incidence of BC if nothing is done to understand the pre-existing risk factors. Preventive measures needed for the two population groups might not be the same across a large country like Tanzania.

Study limitation

Having been set at a tertiary level, the controls might not reflect the environmental influence on the studied risks since cases and controls were not matched based on regional status. We observed that controls were mostly from urban setting hence reaching a conclusion on rural vs urban became difficult. Future studies should match based on this factor too. Furthermore, with the recent improvement in hospital and cancer services in some regions, the cases might not reflect the true population of the Tanzanian population. Hence we propose a multicenter, in country case control study to fully understand the breast cancer risk factors among Tanzanian women.

Recall bias could not be ruled out, especially in older women: recalling precisely menarche and obesity seemed challenging. There was a failure to age match the cases with controls which might fail to expose the true impact of the evaluated risk factors. Even though the sample size had the power to detect the significant odds, but the prevalence of exposure in some of the control variables did not reach the 30% needed for this study. Additionally, anthropometric measurements are needed to further evaluate their role rather than relying on reported self-feeling of obesity.

Conclusion

We have demonstrated that older age at menopause has an increased risk for the development of BC among indigenous Tanzanian women. The remainder of the hormonal, reproductive, lifestyle and nutritional factors had non-conclusive results though they had suggested some causative association: more studies are needed to further evaluate their role. This study is important in shedding light on the plausible role of modifiable risk factors for breast cancer among indigenous African women in Sub Saharan Africa.

Supporting information

S1 File. English version of BC risk questionnaire.

(PDF)

S2 File. Swahili translation of the English questionnaire.

(PDF)

S1 Data. SPSS data set of the study.

(SAV)

Acknowledgments

We acknowledge all residents’ class of 2016/2019 for their contribution in the management of breast cancer patients who were recruited in this study. Secondly, our department secretary Mrs. Agatha Haule, for her secretarial helps with the writing.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021. May;71(3):209–249. doi: 10.3322/caac.21660 [DOI] [PubMed] [Google Scholar]
  • 2.Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, et al. The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005. Dec;6(5):391–401. doi: 10.3816/cbc.2005.n.043 [DOI] [PubMed] [Google Scholar]
  • 3.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. Nov;68(6):394–424. doi: 10.3322/caac.21492 [DOI] [PubMed] [Google Scholar]
  • 4.Global Cancer Observatory. Tanzania, United Republic Of:2020. www.https://gco.iarc.fr/.
  • 5.Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer. 2006. Jan;6(1):63–74. doi: 10.1038/nrc1781 [DOI] [PubMed] [Google Scholar]
  • 6.Porter P. "Westernizing" women’s risks? Breast cancer in lower-income countries. N Engl J Med. 2008. Jan 17;358(3):213–6. doi: 10.1056/NEJMp0708307 [DOI] [PubMed] [Google Scholar]
  • 7.Anderson BO, Ilbawi AM, El Saghir NS. Breast cancer in low and middle income countries (LMICs): a shifting tide in global health. Breast J. 2015. Jan-Feb;21(1):111–8. doi: 10.1111/tbj.12357 [DOI] [PubMed] [Google Scholar]
  • 8.Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6(6):229–39. doi: 10.1186/bcr932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993. Nov 17;85(22):1819–27. doi: 10.1093/jnci/85.22.1819 [DOI] [PubMed] [Google Scholar]
  • 10.Barnard ME, Boeke CE, Tamimi RM. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta. 2015. Aug;1856(1):73–85. doi: 10.1016/j.bbcan.2015.06.002 [DOI] [PubMed] [Google Scholar]
  • 11.Cramer DW. The epidemiology of endometrial and ovarian cancer. Hematol Oncol Clin North Am. 2012. Feb;26(1):1–12. doi: 10.1016/j.hoc.2011.10.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bosco JL, Palmer JR, Boggs DA, Hatch EE, Rosenberg L. Cardiometabolic factors and breast cancer risk in U.S. black women. Breast Cancer Res Treat. 2012. Aug;134(3):1247–56. doi: 10.1007/s10549-012-2131-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Perrine CG, Nelson JM, Corbelli J, Scanlon KS. Lactation and Maternal Cardio-Metabolic Health. Annu Rev Nutr. 2016. Jul 17;36:627–45. doi: 10.1146/annurev-nutr-071715-051213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002. Jul 20;360(9328):187–95. doi: 10.1016/S0140-6736(02)09454-0 [DOI] [PubMed] [Google Scholar]
  • 15.Millikan RC, Newman B, Tse CK, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat. 2008;109(1):123–139. doi: 10.1007/s10549-007-9632-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ambrosone CB, Zirpoli G, Ruszczyk M, et al. Parity and breastfeeding among African-American women: differential effects on breast cancer risk by estrogen receptor status in the Women’s Circle of Health Study. Cancer Causes Control. 2014;25(2):259–265. doi: 10.1007/s10552-013-0323-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lambertini M, Santoro L, Del Mastro L, Nguyen B, Livraghi L, Ugolini D, et al. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies. Cancer Treat Rev. 2016. Sep; 49():65–76. doi: 10.1016/j.ctrv.2016.07.006 [DOI] [PubMed] [Google Scholar]
  • 18.Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, et al. Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysis. Ann Oncol. 2015;26(12):2398–2407. doi: 10.1093/annonc/mdv379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Phipps AI, Li CI. Breastfeeding and triple-negative breast cancer: potential implications for racial/ethnic disparities. J Natl Cancer Inst. 2014. Sep 15;106(10):dju281. doi: 10.1093/jnci/dju281 [DOI] [PubMed] [Google Scholar]
  • 20.Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Ogweyo P, Eissa MS, et al. Clinical and Epidemiologic Profile of Breast Cancer in Tanzania. Breast Dis. 2010; 31(1): 33–41.doi: 10.3233/BD-2009-0296 doi: 10.3233/BD-2009-0296 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A. Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. Pan Afr Med J. 2014. Apr 5;17:249. doi: 10.11604/pamj.2014.17.249.330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993;15(1):48–65. doi: 10.1093/oxfordjournals.epirev.a036116 [DOI] [PubMed] [Google Scholar]
  • 23.Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr. 2000;(27):135–45. doi: 10.1093/oxfordjournals.jncimonographs.a024237 [DOI] [PubMed] [Google Scholar]
  • 24.Nur U, El-Reda D, Hashim D, Weiderpass E. A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the Swedish women’s lifestyle and health cohort. BMC Cancer 19, 807 (2019). 10.1186/s12885-019-5985-6. doi: 10.1186/s12885-019-5985-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chu SY, Lee NC, Wingo PA, Senie RT, Greenberg RS, Peterson HB. The relationship between body mass and breast cancer among women enrolled in the Cancer and Steroid Hormone Study. J Clin Epidemiol. 1991;44(11):1197–206. doi: 10.1016/0895-4356(91)90152-y [DOI] [PubMed] [Google Scholar]
  • 26.Lubin F, Ruder AM, Wax Y, Modan B. Overweight and changes in weight throughout adult life in breast cancer etiology. A case-control study. Am J Epidemiol. 1985. Oct;122(4):579–88. doi: 10.1093/oxfordjournals.aje.a114137 [DOI] [PubMed] [Google Scholar]
  • 27.Martin LJ, Boyd NF. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008;10(1):201. doi: 10.1186/bcr1831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Terry MB, Zhang FF, Kabat G, Britton JA, Teitelbaum SL, Neugut AI, et al. Lifetime alcohol intake and breast cancer risk. Ann Epidemiol. 2006. Mar;16(3):230–40. doi: 10.1016/j.annepidem.2005.06.048 [DOI] [PubMed] [Google Scholar]
  • 29.Reynolds P. Smoking and breast cancer. J Mammary Gland Biol Neoplasia. 2013. Mar;18(1):15–23. doi: 10.1007/s10911-012-9269-x [DOI] [PubMed] [Google Scholar]
  • 30.International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans tobacco smoking. Lyon, France: IARC Press; 2012. pp. 92–101. [Google Scholar]
  • 31.Kawai M, Malone KE, Tang MT, Li CI. Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Cancer. 2014. Apr 1;120(7):1026–34. doi: 10.1002/cncr.28402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fei X, Wu J, Kong Z, Christakos G. Urban-Rural Disparity of Breast Cancer and Socioeconomic Risk Factors in China. PLoS ONE. 2015. Feb; 10(2): e0117572. doi: 10.1371/journal.pone.0117572 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Wen D, Wen X, Yang Y, Chen Y, Wei L, He Y, et al. Urban rural disparity in female breast cancer incidence rate in China and the increasing trend in parallel with socioeconomic development and urbanization in a rural setting. Thorac Cancer. 2018. Feb; 9(2): 262–272. doi: 10.1111/1759-7714.12575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Nagrani R., Mhatre S., Boffetta P., et al. Understanding rural–urban differences in risk factors for breast cancer in an Indian population. Cancer Causes Control 27, 199–208 (2016). doi: 10.1007/s10552-015-0697-y [DOI] [PubMed] [Google Scholar]
  • 35.Zahnd WE, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, et al. Rural–Urban Differences in Cancer Incidence and Trends in the United States. Cancer Epidemiol Biomarkers Prev. 2018. Nov;27(11):1265–1274. doi: 10.1158/1055-9965.EPI-17-0430 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

David Teye Doku

23 Jun 2021

PONE-D-21-08470

The effect of reproductive, hormonal, nutritional and lifestyle risk on breast cancer among black Tanzanian women: A case control Study.

PLOS ONE

Dear Dr. Akoko,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 07 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

David Teye Doku

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as

a) a description of all inclusion/exclusion criteria that were applied to participant recruitment,

b) a statement as to whether your sample can be considered representative of a larger population, and

c) a description of how participants were recruited.

3. Thank you for stating in the text of your manuscript "Written informed consent was obtained in Swahili from all participants before enrolment. " Please also add this information to your ethics statement in the online submission form.

4. Please include additional information regarding the survey or questionnaire used in the study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed the survey or questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information. If the questionnaire is published, please provide a citation to the (1) questionnaire and/or (2) original publication associated with the questionnaire.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review of the Manuscript entitled :-

“The effect of reproductive, hormonal, nutritional and lifestyle risk on breast cancer among black Tanzanian women: A case control Study”

Abstract:

� In the Purpose: The word “Life style” which was mentioned in the main Title is not mentioned here.

� In Results:

• In line 40-41 the word “Smoking” was unnecessary repeated twice (smoking ¬– cigarette smoking)

• Line 42 , Nulliparity is missed here.

Manuscript:

• Line 1: in Full title: Life style is missed

• Line 53: in Key words: Tanzanian women could be added

• Line 96: in Study subjects: age range of the studied sample should be added.

• Lines 189 & 191: values of P & CI to be matched with the table

• Line 214-216: if these results are of the present study please mention if not add a reference

• Line 267: should be explained more clearly e.g.” In rural areas the % of cases was more than that of controls and the difference was significant, (47.6% cases vs 33.7% controls, p 0.019)”

• In the whole study: The study neglected to evaluate the potential effect of nutritional risk factors for the development of breast cancer throughout the results as well as the discussion although it was mentioned in the methodology.

• References: the last resent reference is from 2019, it would be better to add some more recent ones.

General Comments on Statistics

1. As shown in the results, there was a significant difference between the mean ages of cases and controls which denote that controls were not properly age matched with cases, (P= 0.006).

2. Regarding Residence we can notice contradictory results: while in Table-1-, for rural residencies there was a significant risk for BC (p=0.019), in Table-2 & 3, rural residencies have a protective effect regarding BC, (P=0.019, OR 0.56 & P=0.22, AOR 0.61 respectively).

3. Regarding Age at menopause:

a. In Table -2- it was mentioned that age at menopause < 45 is a sig. risk ( P=0.07, OR 2.26), while in Table -3- age ≥ 45 had 2.6 fold increase risk of developing BC and is significant (P= 0.047, AOR 2.63).

b. Changing the order of the risk factor (<45 and ≥ 45) in the statistical analysis (Tables 2 &3) led to such contradictory results.

Reviewer #2: The submitted manuscript entitled (The effect of reproductive, hormonal, nutritional and lifestyle risk on breast cancer among black Tanzanian women: A case control Study) aimed to define some environmental factors that may play a role in the breast cancer such as hormones and nutrients according to the lifestyle.

The manuscript is a case study and well-presented and is a representative for the factors under investigation.

There are few minor comments:

1- Line 159: as mentioned that cases were significantly older and came from rural residences. However, the results showing that the number and percentage of urban is more than the rural in both control and cases.

2- For the age parameter, it is difficult to consider the average as a realistic so as I understood that it is analyzed later in details. However, it is still confusing about the age between 12 and 45.

3- The discussion part requires some modification to be more solid and informative.

4- The lifestyle part of discussion especially the part of residency as the results in table 2 showed that the more cases and controls came from urban in contrast to the discussion part.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Fatma Ahmed El Sayed Shaaban

Reviewer #2: Yes: Ahmed K Elsayed

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer comments.docx

PLoS One. 2022 Feb 9;17(2):e0263374. doi: 10.1371/journal.pone.0263374.r002

Author response to Decision Letter 0


4 Aug 2021

20th July, 2021

Dear editor

Thanks again for giving us the opportunity to critically scrutinize our paper after reviewer’s comments and those of your own. I have incorporated the response to all the comments as was appropriately demanded. Secondly, I have adhered to the journal stylistic demands for the body and tittle page. Likewise, the supporting section has been added accordingly including both versions of the questionnaire used in this study.

a) You suggested that we add participant’s recruitment methods and their demographics in the methodology section which we have now made. We have a subsection that is addressing only recruitment of cases and controls detailing how the recruitment was made with detailed inclusion and exclusion criteria

b) On whether our sample size can be considered representative of a larger population yes and no. Most of the breast cancer patients in the country that make it to a treatment facility will end at our hospital. However, there is a possibility that there are patients who will succumb before reaching us. Likewise, medical patients might not be drawn for the entire country since their conditions are treatable in many other facilities across the country. This had the potential of bringing a mismatch between cases and controls on geographical risk if any exists. We have added this to the discussion “Para 1 line 212-214 (Since breast cancer is known to be a heterogeneous disease, the sample of women studied can only serve a snapshot of Tanzanian women but might not be generalized for all BC patients)”

c) We have added the consent statement “Written informed consent was obtained in Swahili from all participants before enrolment." To the submission portal

d) We have attached both versions of the survey as S1 Files 1 – 2

e) The caption for the supporting files has been added right after the references.

f) In addressing first issue as to whether the manuscript is technically sound, we have changed significantly issues that worried the reviewers and we now believe it is sound and that our conclusion is drawn from the results. Secondly, we have addressed the statistical issue that worried reviewer 1 adequately and I hope Prof.(Ms.) Fatma will be satisfied now.

g) We have also used the latest GLOBOCAN statistics publication of 2020 and added four more references to enrich our discussion section.

Reviewer #1 comments with responses

“The effect of reproductive, hormonal, nutritional and lifestyle risk on breast cancer among black Tanzanian women: A case control Study” I had actually changed my submission tittle to read the” The effect of reproductive, hormonal and nutritional risk on breast cancer among Black Tanzanian women: A case control Study. I had considered lifestyle to be covered under nutritional factors. But I have now added the lifestyle in the tittle.

Abstract

• In the Purpose: The word “Life style” which was mentioned in the main Title is not mentioned here. So in the tittle that was on the main document I did not include the word “Life style. But now it has been added.”

• In Results:

• In line 40-41 the word “Smoking” was unnecessary repeated twice (smoking ¬– cigarette smoking): the first smoking has been removed

• Line 42, Null parity is missed here. Nulliparity was not brought to the multinomial analysis. Null parity was a rare event among Tanzanian women hence the numbers were not worth making conclusion on.

Manuscript

• Line 1: in Full title: Life style is missed. I thought of shortening the tittle as explained in above. But I have inserted the ,’lifestyle’

• Line 53: in Key words: Tanzanian women could be added. This has been added

• Line 96: in Study subjects: age range of the studied sample should be added. I have inserted the age ranges for the cases and that of the cohort in line……

• Lines 189 & 191: values of P & CI to be matched with the table. These have been added

• Line 214-216: if these results are of the present study please mention if not add a reference. The reference has been added. Actually it was assumed to be covered in the preceding line. Reference …. Actually was referring to the statement, it was a bad referencing.

• Line 267: should be explained more clearly e.g.” In rural areas the % of cases was more than that of controls and the difference was significant, (47.6% cases vs 33.7% controls, p 0.019)”. This was actually an overlook of the actual data that we presented in the table. Most of the cases had urban residence compared to rural residence. This could partly be explained that that hospital was itself located in an urban setting, and whether all women with BC in Tanzania make it to the hospital remains unknown.

• In the whole study: The study neglected to evaluate the potential effect of nutritional risk factors for the development of breast cancer throughout the results as well as the discussion although it was mentioned in the methodology. I must admit that we only looked at the consequence of nutrition, that is obesity at childhood, and not the dietary issues as we thought it would have been too wide to cover. In the discussion, we therefore combined the obesity with other lifestyles issues as one.

• References: the last resent reference is from 2019, it would be better to add some more recent ones. BC risk factor might be an old topic in the developed world but which has received little attention in the LMICs. However, I have updated the GLOBOCAN reference to bring the most recent one of 2020.

General Comments on Statistics

1. As shown in the results, there was a significant difference between the mean ages of cases and controls which denote that controls were not properly age matched with cases, (P= 0.006). I take it as a failure in matching. As we indicated in the methodology, the ±5 was the same difference at analysis which turned significant. Both cases and controls were under 50 years of age which was somewhat a success in the matching. But we admit this in the limitations of our study, now added.

2. Regarding Residence we can notice contradictory results: while in Table-1-, for rural residencies there was a significant risk for BC (p=0.019), in Table-2 & 3, rural residencies have a protective effect regarding BC, (P=0.019, OR 0.56 & P=0.22, AOR 0.61 respectively). I have admitted in the comment on line 264 above that it was an oversight. Actually most patients had urban residence and so were the controls. So I have changed the discussion as well to reflect this.

3. Regarding Age at menopause:

a. In Table -2- it was mentioned that age at menopause < 45 is a sig. risk ( P=0.07, OR 2.26), while in Table -3- age ≥ 45 had 2.6 fold increase risk of developing BC and is significant (P= 0.047, AOR 2.63).

b. Changing the order of the risk factor (<45 and ≥ 45) in the statistical analysis (Tables 2 &3) led to such contradictory results. Totally agree, there was an error assigning the symbols when making the table. I have rerun the SPSS and the changes made and the previous interpretation is correct.

Reviewer #2

The submitted manuscript entitled (The effect of reproductive, hormonal, nutritional and lifestyle risk on breast cancer among black Tanzanian women: A case control Study) aimed to define some environmental factors that may play a role in the breast cancer such as hormones and nutrients according to the lifestyle.

The manuscript is a case study and well-presented and is a representative for the factors under investigation. Thanks for this positive and encouraging observation made on our paper.

There are few minor comments:

1. Line 159: as mentioned that cases were significantly older and came from rural residences. However, the results showing that the number and percentage of urban is more than the rural in both control and cases. I have regrettably noted this serious error and appropriate correction has been made.

2. For the age parameter, it is difficult to consider the average as a realistic so as I understood that it is analyzed later in details. However, it is still confusing about the age between 12 and 45. Age at menarche is the one which was taken at 12 as cut off for early or late menarche, while 45 was taken as cut off for early or late menopause.

3. The discussion part requires some modification to be more solid and informative.

4. The lifestyle part of discussion especially the part of residency as the results in table 2 showed that the more cases and controls came from urban in contrast to the discussion part. Addressed taken care of as in your first comment above

Larry Akoko

Corresponding author

Senior Lecturer

Department of surgery

Muhimbili University of Health and Allied sciences

Attachment

Submitted filename: Response letter.docx

Decision Letter 1

David Teye Doku

9 Sep 2021

PONE-D-21-08470R1The effect of reproductive, hormonal, nutritional and lifestyle risk on breast cancer among black Tanzanian women: A case control Study.PLOS ONE

Dear Dr. Akoko,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================Kindly address the issue raised by reviewer before final decision on your manuscript can be made. Please ensure that your decision is justified on PLOS ONE’s publication criteria and not, for example, on novelty or perceived impact.

For Lab, Study and Registered Report Protocols: These article types are not expected to include results but may include pilot data. 

==============================

Please submit your revised manuscript by Oct 24 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

David Teye Doku

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Line 182-184, "Controls and cases were similar in all aspects except for age where by cases were about five years younger (p=0.006), and there were 13.9% control group coming from urban residence (p=0.19)

- cases were younger OR older by 5 years ( for cases mean age = 49.55 while for controls it was 44.95)

- The % of control coming from urban residence is ( 66.3%) & not 13.9%, (p=0.019).

Reviewer #2: The author covered all the comments in the revised version. It sounds good from the technical view and english writing.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Prof. Fatma Ahmed El-Sayed Shaaban

Reviewer #2: Yes: Ahmed Kamel Elsayed

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

David Teye Doku

19 Jan 2022

The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among Black Tanzanian women: A case control Study.

PONE-D-21-08470R2

Dear Dr. Akoko,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

David Teye Doku

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

None.

Reviewers' comments:

Acceptance letter

David Teye Doku

28 Jan 2022

PONE-D-21-08470R2

The effect of reproductive, hormonal, nutritional and lifestyle on breast cancer risk among Black Tanzanian women: A case control Study.

Dear Dr. Akoko:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. David Teye Doku

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. English version of BC risk questionnaire.

    (PDF)

    S2 File. Swahili translation of the English questionnaire.

    (PDF)

    S1 Data. SPSS data set of the study.

    (SAV)

    Attachment

    Submitted filename: Reviewer comments.docx

    Attachment

    Submitted filename: Response letter.docx

    Attachment

    Submitted filename: Rebutal letter.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES